Analyzing the Blueprint: Exploring the Molecular Profile of Metastasis and Therapeutic Resistance

Area of Science:

• Oncology
• Cancer Biology
• Immunology

Background:

• Metastases are the primary cause of cancer mortality, characterized by unique molecular profiles.
• Metastatic lesions display genomic instability, copy number alterations (CNAs), and altered metabolic pathways, including fatty acid oxidation (FAO).
• The tumor microenvironment involves complex interactions between cancer cells, immune cells like macrophages and neutrophils, and the tumor microbiome.

Purpose of the Study:

• To examine the genomic features of metastatic tumors.
• To investigate the metabolic and immunological dynamics within the metastatic tumor microenvironment.
• To elucidate molecular mechanisms of chemoresistance in metastatic cancers.

Main Methods:

• Genomic analysis of metastatic tumors.
• Assessment of metabolic adaptations, including fatty acid oxidation (FAO).
• Evaluation of immune cell infiltration and function (macrophages, neutrophils) within the tumor microenvironment.

Main Results:

• Metastases exhibit chromosomal instability, copy number alterations (CNAs), and reduced subclonality.
• Enhanced glycogen synthesis and fatty acid oxidation (FAO) support metastatic energy demands and chemoresistance.
• FAO influences macrophage polarization to an immunosuppressive M2 phenotype.
• Neutrophil extravasation and chemoresistant neutrophils contribute to immune suppression and drug resistance via neutrophil extracellular traps (NETs).

Conclusions:

• Genomic, metabolic, and immunological factors converge to drive metastasis and chemoresistance.
• Targeting metabolic pathways and the tumor immune microenvironment presents potential therapeutic strategies.
• Understanding these complex interactions is crucial for overcoming treatment resistance in metastatic cancers.